The aim of the study was analysis of the cases, where histopathological examination failed to confirm the presence of breast microcalcifications in the SMB (stereotactic mammotome biopsy) specimens. Between 2000-2004, 242 patients underwent SMB under the guidance of digital mammography to verify breast microcalcification clusters of BI-RADS (Breast Imaging Reporting and Data System) 3-5 categories. In 39 of these patients histopathological examination did not confirm microcalcifications despite visualization on the radiograms. All such cases were additionally evaluated under polarized light microscope to detect microcalcifications containing birefringent calcium oxalate deposits. In all 39 patients only benign breast abnormalities were detected. In none of these cases breast microcalcifications were revealed in the additional evaluation under polarized light microscope. In some cases histopathological examination of the SMB specimens of breast microcalcifications may not confirm their presence despite visualization on the radiograms. The bioptates sent for the examination should he placed in the order of sampling at the same level and in such form embedded in the paraffin blocks. Radiograms confirming the location of microcalcifications should accompany the specimens. If standard assessment does not demonstrate microcalcifications, serial cutting and additional evaluation under polarized light microscope are recommended.

Download full-text PDF

Source

Publication Analysis

Top Keywords

histopathological examination
12
breast microcalcifications
12
polarized light
12
light microscope
12
breast microcalcification
8
microcalcification clusters
8
stereotactic mammotome
8
mammotome biopsy
8
biopsy specimens
8
cases histopathological
8

Similar Publications

Myofibroblastoma is a rare mesenchymal tumour known for its benign nature but complex diagnostic pathway. A woman in her 40s presented with a painless breast mass, initially reported as a fibroadenoma on ultrasound mammography and as a benign to borderline phyllodes tumour on fine needle aspiration cytology. Contrast-enhanced CT was reported as carcinoma of the breast with Breast Imaging and Reporting Data System (BIRADS)-6.

View Article and Find Full Text PDF

Background: Lentigo maligna (LM) and lentigo maligna melanoma (LMM) are the most prevalent subtypes of melanoma, primarily affecting sun-exposed areas of the face in individuals aged 65 to 80 years. LM accounts for approximately 80 % of in situ melanomas and carries a risk of progression to LMM, which constitutes 4 % to 15 % of global cutaneous melanoma cases. This report discusses the clinical challenges and management strategies for recurrent LM, with an emphasis on accurate diagnosis and surgical intervention.

View Article and Find Full Text PDF

Evaluation of drug-drug interaction between rosuvastatin and tacrolimus and the risk of hepatic injury in rats.

Naunyn Schmiedebergs Arch Pharmacol

January 2025

Department of Organ Transplantation, The Second Affiliated Hospital of Nanchang University, Minde Road No. 1, Nanchang, 330006, Jiangxi, China.

Multimorbidity, therapeutic complexity, and polypharmacy, which greatly increases the risk of drug-drug interactions (DDIs) and adverse medical outcomes, have become important and growing challenges in clinical practice. Statins are frequently prescribed to manage post-transplant dyslipidemia and reduce overall cardiovascular risk in solid organ transplant recipients. This study aimed to determine whether rosuvastatin has significant DDIs with tacrolimus (the first-line immunosuppressant) and to evaluate the risk of hepatotoxicity associated with concomitant therapy.

View Article and Find Full Text PDF

Purpose: This study aimed to identify if a subset of men can safely avoid or delay prostate biopsy based on negative results of prostate-specific membrane antigen positron emission tomography (PSMA-PET).

Materials And Methods: Among 341 consecutive cases in a prospective biopsy cohort (NCT05073653), 111 treatment-naïve men with negative PSMA-PET (PRIMARY-score 1/2) were included. All participants underwent PSMA-PET and histopathological examinations.

View Article and Find Full Text PDF

Therapeutic Potential of (L.) . Leaf Extract in Modulating Gut Microbiota and Immune Response for the Treatment of Inflammatory Bowel Disease.

Pharmaceuticals (Basel)

January 2025

School of Life and Health Sciences, Hainan Province Key Laboratory of One Health, Collaborative Innovation Center of One Health, Hainan University, No. 58 Renmin Avenue, Haikou 570228, China.

Inflammatory bowel disease (IBD) is a persistent inflammatory condition affecting the gastrointestinal tract, distinguished by the impairment of the intestinal epithelial barrier, dysregulation of the gut microbiota, and abnormal immune responses. (L.) , traditionally used in Chinese herbal medicine for gastrointestinal issues such as bleeding and dysentery, has garnered attention for its potential therapeutic benefits.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!